Lancet:经腹中线的剖腹手术关腹时,筋膜的缝合针距应选择5mm还是1cm?

2015-10-19 Mechront 译 MedSci原创

经腹中线的剖腹手术常常容易并发切口疝,该中线切口线常常发病率高,显著降低患者生活质量,并且花费也会更大。因此研究者进行了一项双盲、多中心、随机对照试验探究经腹中线剖腹手术在关腹的时候,对于筋膜的缝合应选择大口大口的缝合还是小口小口的缝合,哪种缝合方式更有益。该研究在荷兰的10家医院的外科和妇科部门进行,研究对象均为≥18岁,准备进行平诊的经腹中线剖腹手术,并按1:1随机分为2组,一组筋膜缝合选择针

经腹中线的剖腹手术常常容易并发切口疝,该中线切口线常常发病率高,显著降低患者生活质量,并且花费也会更大。因此研究者进行了一项双盲、多中心、随机对照试验探究经腹中线剖腹手术在关腹的时候,对于筋膜的缝合应选择大口大口的缝合还是小口小口的缝合,哪种缝合方式更有益。

该研究在荷兰的10家医院的外科和妇科部门进行,研究对象均为≥18岁,准备进行平诊的经腹中线剖腹手术,并按1:1随机分为2组,一组筋膜缝合选择针距5mm,另一组为1cm。初始结局指标为切口疝的发生率。

2009年10月20日-2012年3月12日间共有560名患者参与该研究,其中5mm组有284人,1cm组有276人,随访至2013年8月30日,共有545 (97%) 名病人完成了随访,结果纳入分析研究。

5mm组显然会比1cm组筋膜上有更多的针眼(45 [SD 12] vs 25 [10]; p<0.0001);相对于伤口长度,5mm组的筋膜缝合长度更长(5.0 [1.5] vs 4.3 [1.4]; p<0.0001);并且5mm组需要的缝合时间更长(14 [6] vs 10 [4] min; p<0.0001)。研究者1年的随访期间发现,1cm组有57/277(21%)例切口疝发生,5mm组该数据为35/268(13%)(p=0.0220, aOR 0.52, 95% CI 0.31-0.87; p=0.0131)。不良反应事件在两组中没有显著差异。

研究结果表明,对经腹中线的剖腹手术,筋膜的缝合选择小口缝合(针距5mm)会比大口缝合(1cm)在预防切口疝的发生上更有效,并且没有观察到不良反应事件的发生。


MedSci小编提示:

就这么low的课题,也能发Lancet?天天咱都在剖腹,开腹,怎么就没有想到呢?从临床操作角度,腹中线旁开1cm,手术视野比较方便,但是考虑过长期的并发症了吗?一点小小的改变,可能就是能改变临床常规和习惯的重大研究!

原始出处:

Deerenberg EB, Harlaar JJ, Steyerberg EW,et al.Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial.Lancet. 2015 Sep 26;386(10000):1254-60.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1828258, encodeId=4b44182825823, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 14 03:43:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951080, encodeId=51661951080b5, content=<a href='/topic/show?id=b042855225e' target=_blank style='color:#2F92EE;'>#腹中线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85522, encryptionId=b042855225e, topicName=腹中线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Thu Nov 12 03:43:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40533, encodeId=5056405331d, content=看文章我也是这么想,这玩意也能发Lancet?, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=829a1658104, createdName=1dde1abbm71(暂无匿称), createdTime=Sat Oct 24 01:16:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=39889, encodeId=683d39889f7, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Tue Oct 20 11:07:00 CST 2015, time=2015-10-20, status=1, ipAttribution=)]
    2016-09-14 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1828258, encodeId=4b44182825823, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 14 03:43:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951080, encodeId=51661951080b5, content=<a href='/topic/show?id=b042855225e' target=_blank style='color:#2F92EE;'>#腹中线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85522, encryptionId=b042855225e, topicName=腹中线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Thu Nov 12 03:43:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40533, encodeId=5056405331d, content=看文章我也是这么想,这玩意也能发Lancet?, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=829a1658104, createdName=1dde1abbm71(暂无匿称), createdTime=Sat Oct 24 01:16:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=39889, encodeId=683d39889f7, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Tue Oct 20 11:07:00 CST 2015, time=2015-10-20, status=1, ipAttribution=)]
    2015-11-12 zz70
  3. [GetPortalCommentsPageByObjectIdResponse(id=1828258, encodeId=4b44182825823, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 14 03:43:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951080, encodeId=51661951080b5, content=<a href='/topic/show?id=b042855225e' target=_blank style='color:#2F92EE;'>#腹中线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85522, encryptionId=b042855225e, topicName=腹中线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Thu Nov 12 03:43:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40533, encodeId=5056405331d, content=看文章我也是这么想,这玩意也能发Lancet?, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=829a1658104, createdName=1dde1abbm71(暂无匿称), createdTime=Sat Oct 24 01:16:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=39889, encodeId=683d39889f7, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Tue Oct 20 11:07:00 CST 2015, time=2015-10-20, status=1, ipAttribution=)]
    2015-10-24 1dde1abbm71(暂无匿称)

    看文章我也是这么想,这玩意也能发Lancet?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1828258, encodeId=4b44182825823, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 14 03:43:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951080, encodeId=51661951080b5, content=<a href='/topic/show?id=b042855225e' target=_blank style='color:#2F92EE;'>#腹中线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85522, encryptionId=b042855225e, topicName=腹中线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Thu Nov 12 03:43:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40533, encodeId=5056405331d, content=看文章我也是这么想,这玩意也能发Lancet?, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=829a1658104, createdName=1dde1abbm71(暂无匿称), createdTime=Sat Oct 24 01:16:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=39889, encodeId=683d39889f7, content=有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Tue Oct 20 11:07:00 CST 2015, time=2015-10-20, status=1, ipAttribution=)]
    2015-10-20 lixh1719

    有意义

    0

相关资讯

JAMA:推荐减重手术后的长期随访:一项系统评价

作者:南希·普齐费里(Puzziferri)等 美国达拉斯市得克萨斯大学西南医学中心外科系等 意义减重手术是一种被接受的肥胖治疗方法。尽管有大量文献(发表),但对有足够保留率的队列进行长期随访的研究报告并不多。 目的 在重度肥胖成人减重手术2年后,评估有关体重减轻、2型糖尿病、高血压和高脂血症的治疗效果及证据质量。 证据评估检索MEDLINE和Cochrane数据库中19